Department of Radiology, University of Cincinnati Medical Center, 234 Goodman Street ML 0772, Cincinnati, OH 45219-0772, United States of America.
One Kenwood Place, 9825 Kenwood Road, Suite 105, Cincinnati, OH 45242, United States of America.
Clin Imaging. 2021 Nov;79:125-132. doi: 10.1016/j.clinimag.2021.04.013. Epub 2021 Apr 29.
To evaluate the diagnostic performance of abbreviated MRI (AB-MRI) in comparison to a full protocol MRI (FP-MRI) when evaluating common MRI abnormalities of a mass, non-mass enhancement and focus.
This retrospective reader study was Institutional Review Board approved and Health Insurance Portability and Accountability Act (HIPAA) compliant. AB-MRIs were reviewed from May 2018-December 2019 to identify women with an abnormal AB-MRI, FP-MRI within six months of the AB-MRI and an elevated risk for breast cancer. Six breast radiologists initially interpreted and recorded findings from the AB-MRI. Immediately after reviewing the AB-MRI, the same radiologists interpreted and recorded findings from the FP-MRI. Findings were recorded in an electronic data collection form. Cohen's Kappa test was used to calculate agreement. P < 0.05 was considered statistically significant.
Of 119 patients who had an AB-MRI, our final study comprised of 32 patients who had 64 breast MRIs (32 AB-MRI and 32 FP-MRI). The amount of fibroglandular tissue for AB-MRI and FP-MRI showed excellent intra-reader agreement [Kappa: 0.89-1.00 (P < 0.0001)]. Substantial to excellent intra-reader agreement [Kappa: 0.74-0.93 (P < 0.0001)] was demonstrated for all 6 readers when identifying abnormalities seen on AB-MRI and FP-MRI. Moderate to excellent intra-reader agreement [Kappa: 0.41-0.87(P < 0.0001)] was demonstrated between the AB-MRI and FP-MRI for the final BI-RADS assessment.
AB-MRI has acceptable intra-reader agreement with FP-MRI when characterizing common MRI abnormalities such as a mass, non-mass enhancement and focus suggesting that subsequent FP-MRI may not be needed.
评估缩短磁共振成像(AB-MRI)与全协议磁共振成像(FP-MRI)在评估肿块、非肿块强化和病灶等常见 MRI 异常时的诊断性能。
本回顾性读者研究获得了机构审查委员会的批准,并符合《健康保险流通与责任法案》(HIPAA)。从 2018 年 5 月至 2019 年 12 月,对 AB-MRI 异常的女性进行了 AB-MRI 和 FP-MRI 的回顾性检查,且这些女性在 AB-MRI 后 6 个月内有乳腺癌的高风险。6 位乳腺放射科医生最初对 AB-MRI 进行了解读并记录了检查结果。在查看 AB-MRI 后,同一位放射科医生立即对 FP-MRI 进行了解读并记录了检查结果。结果记录在电子数据采集表中。采用 Cohen Kappa 检验来计算一致性。P 值<0.05 被认为具有统计学意义。
在 119 例接受 AB-MRI 的患者中,我们的最终研究纳入了 32 例患者的 64 例乳腺 MRI(32 例 AB-MRI 和 32 例 FP-MRI)。AB-MRI 和 FP-MRI 的纤维腺体组织量显示出极好的读者内一致性[Kappa:0.89-1.00(P<0.0001)]。当识别 AB-MRI 和 FP-MRI 上的异常时,所有 6 位读者均表现出显著到极好的读者内一致性[Kappa:0.74-0.93(P<0.0001)]。AB-MRI 和 FP-MRI 的最终 BI-RADS 评估之间表现出中度到极好的读者内一致性[Kappa:0.41-0.87(P<0.0001)]。
AB-MRI 在描述肿块、非肿块强化和病灶等常见 MRI 异常方面与 FP-MRI 具有可接受的读者内一致性,这表明后续的 FP-MRI 可能不是必需的。